Dennis M. Lanfear - 20 Jan 2026 Form 4 Insider Report for Coherus Oncology, Inc. (CHRS)

Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Dennis M. Lanfear
Issuer symbol
CHRS
Transactions as of
20 Jan 2026
Net transactions value
-$18,350
Form type
4
Filing time
22 Jan 2026, 20:50:01 UTC
Previous filing
09 May 2025
Next filing
26 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lanfear Dennis M President & CEO, Director C/O COHERUS ONCOLOGY, INC., 333 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY /s/ Bryan McMichael, as Attorney-in-Fact for Dennis M. Lanfear 22 Jan 2026 0001420822

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability $18,350 -11,839 -1.7% $1.55 673,235 20 Jan 2026 Direct F1
holding CHRS Common Stock 432,684 20 Jan 2026 By Trust F2
holding CHRS Common Stock 86,965 20 Jan 2026 By LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.
F2 These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
F3 These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.